Antithrombotic Therapy After Peripheral Vascular Intervention
作者： Peter Hu , Schuyler Jones
DOI: 10.1007/S11886-016-0706-0
关键词: Emergency medicine 、 Clopidogrel 、 Observational study 、 Disease 、 Surgery 、 Medicine 、 P2Y12 、 Critical limb ischemia 、 Randomized controlled trial 、 Antithrombotic 、 Aspirin 、 Cardiology and Cardiovascular Medicine
摘要: Cardioprotective medications and risk-factor modification are the hallmarks of treatment for all patients with peripheral artery disease (PAD). If symptoms life-limiting and/or do not respond to conservative treatment, endovascular or surgical revascularization can be considered especially critical limb ischemia acute ischemia. The rates vascular intervention (PVI) have risen dramatically over past few decades much this care shifted from inpatient hospital settings outpatient office-based clinics. While PVI surged technology advancements changed face PVI, data behind optimal antithrombotic therapy following is scant. Currently in USA, most treated indefinite aspirin a variable duration clopidogrel (or other P2Y12 inhibitor)-typically 1 month, 3 months, therapy. More observational analyses randomized clinical trials evaluating clinically relevant outcomes such as cardiovascular morbidity/mortality risk bleeding needed guide role post-PVI.
springer.com
sci-hub.se 参考文章(42)
Jeffrey S. Berger, Mori J. Krantz, John M. Kittelson, William R. Hiatt, Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease JAMA. ,vol. 301, pp. 1909- 1919 ,(2009) , 10.1001/JAMA.2009.623
Jill JF Belch, John Dormandy, CASPAR Writing Committee, Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial Journal of Vascular Surgery. ,vol. 52, pp. 825- 833 ,(2010) , 10.1016/J.JVS.2010.04.027
Reena L. Pande, Todd S. Perlstein, Joshua A. Beckman, Mark A. Creager, Secondary Prevention and Mortality in Peripheral Artery Disease National Health and Nutrition Examination Study, 1999 to 2004 Circulation. ,vol. 124, pp. 17- 23 ,(2011) , 10.1161/CIRCULATIONAHA.110.003954
Richard V. Milani, Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy? Catheterization and Cardiovascular Interventions. ,vol. 74, ,(2009) , 10.1002/CCD.21996
Lily Thomson, Review of an article: Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. Jill J.F. Belch, MD, FRCP, John Dormandy, MD, FRCS, and the CASPAR Writing Committee, Dundee and London, United Kingdom (J Vasc Surg 2010;52:825-33). Journal of Vascular Nursing. ,vol. 30, pp. 29- 30 ,(2012) , 10.1016/J.JVN.2011.12.001
F Gerald R Fowkes, Jacqueline F Price, Marlene CW Stewart, Isabella Butcher, Gillian C Leng, Alistair CH Pell, Peter AG Sandercock, Keith AA Fox, Gordon DO Lowe, Gordon D Murray, None, Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial IndexA Randomized Controlled Trial JAMA. ,vol. 303, pp. 841- 848 ,(2010) , 10.1001/JAMA.2010.221
Arun K. Thukkani, Scott Kinlay, Endovascular intervention for peripheral artery disease. Circulation Research. ,vol. 116, pp. 1599- 1613 ,(2015) , 10.1161/CIRCRESAHA.116.303503
Philip P. Goodney, Adam W. Beck, Jan Nagle, H. Gilbert Welch, Robert M. Zwolak, National trends in lower extremity bypass surgery, endovascular interventions, and major amputations Journal of Vascular Surgery. ,vol. 50, pp. 54- 60 ,(2009) , 10.1016/J.JVS.2009.01.035
, M. Tendera, V. Aboyans, M.-L. Bartelink, I. Baumgartner, D. Clement, J.-P. Collet, A. Cremonesi, M. De Carlo, R. Erbel, F. G. R. Fowkes, M. Heras, S. Kownator, E. Minar, J. Ostergren, D. Poldermans, V. Riambau, M. Roffi, J. Rother, H. Sievert, M. van Sambeek, T. Zeller, J. Bax, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, A. Torbicki, A. Vahanian, S. Windecker, P. Kolh, A. Torbicki, S. Agewall, A. Blinc, M. Bulvas, F. Cosentino, T. De Backer, A. Gottsater, D. Gulba, T. J. Guzik, B. Jonsson, G. Kesmarky, A. Kitsiou, W. Kuczmik, M. L. Larsen, J. Madaric, J.-L. Mas, J. J. V. McMurray, A. Micari, M. Mosseri, C. Muller, R. Naylor, B. Norrving, O. Oto, T. Pasierski, P.-F. Plouin, F. Ribichini, J.-B. Ricco, L. Ruilope, J.-P. Schmid, U. Schwehr, B. G. M. Sol, M. Sprynger, C. Tiefenbacher, C. Tsioufis, H. Van Damme, , , , ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). European Heart Journal. ,vol. 32, pp. 2851- 2906 ,(2011) , 10.1093/EURHEARTJ/EHR211
Christopher J. White, William A. Gray, Endovascular Therapies for Peripheral Arterial Disease An Evidence-Based Review Circulation. ,vol. 116, pp. 2203- 2215 ,(2007) , 10.1161/CIRCULATIONAHA.106.621391